Upgrade to SI Premium - Free Trial

Trevi Therapeutics (TRVI)

13.46 +0.06 (0.45%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 Trevi Therapeutics, Inc. For: Jun 03 Filed by: Mathers Edward T June 4, 2026 4:28 PM - SEC Filing Form 8-K Trevi Therapeutics, Inc. For: Jun 03 June 4, 2026 4:05 PM - SEC Filing Form 4 Trevi Therapeutics, Inc. For: Jun 03 Filed by: Colangelo Dominick June 4, 2026 4:05 PM - SEC Filing Form 4 Trevi Therapeutics, Inc. For: Jun 03 Filed by: Meeker David P June 4, 2026 4:05 PM - SEC Filing Form 4 Trevi Therapeutics, Inc. For: Jun 03 Filed by: Heffernan Michael Thomas June 4, 2026 4:05 PM - SEC Filing Form 4 Trevi Therapeutics, Inc. For: Jun 03 Filed by: VANLENT ANNE June 4, 2026 4:05 PM - SEC Filing Trevi Therapeutics (TRVI) PT Raised to $30 at Stifel May 8, 2026 8:43 AM - StreetInsider Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P. May 7, 2026 6:23 PM - SEC Filing Form SCHEDULE 13G/A Trevi Therapeutics, Inc. Filed by: FMR LLC May 6, 2026 11:41 AM - SEC Filing Trevi Therapeutics (TRVI) PT Raised to $21 at B.Riley May 6, 2026 9:21 AM - StreetInsider Trevi Therapeutics (TRVI) PT Raised to $20 at Morgan Stanley May 6, 2026 8:15 AM - StreetInsider Trevi Therapeutics (TRVI) PT Lowered to $23 at Needham May 6, 2026 7:21 AM - StreetInsider Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI) May 6, 2026 12:49 AM - StreetInsider Form 10-Q Trevi Therapeutics, Inc. For: Mar 31 May 5, 2026 4:10 PM - SEC Filing Form 8-K Trevi Therapeutics, Inc. For: May 05 May 5, 2026 4:09 PM - SEC Filing Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates May 5, 2026 4:05 PM - Globe NewsWire Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference April 30, 2026 4:05 PM - Globe NewsWire Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026 April 28, 2026 4:05 PM - Globe NewsWire Trevi Therapeutics to Participate in Upcoming May Events April 23, 2026 4:05 PM - Globe NewsWire Form DEF 14A Trevi Therapeutics, Inc. For: Apr 21 April 21, 2026 4:00 PM - SEC Filing Form DEFA14A Trevi Therapeutics, Inc. April 21, 2026 4:00 PM - SEC Filing Form ARS Trevi Therapeutics, Inc. For: Dec 31 April 21, 2026 4:00 PM - SEC Filing Trevi Therapeutics (TRVI) PT Raised to $25 at Leerink Partners April 21, 2026 4:16 AM - StreetInsider Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares April 20, 2026 4:05 PM - Globe NewsWire Form 424B5 Trevi Therapeutics, Inc. April 17, 2026 4:18 PM - SEC Filing Form 8-K Trevi Therapeutics, Inc. For: Apr 16 April 17, 2026 8:07 AM - SEC Filing Trevi Therapeutics prices $150 million stock offering at $13 per share April 16, 2026 10:42 PM - StreetInsider Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock April 16, 2026 10:42 PM - Globe NewsWire After-hours movers: Netflix, Alcoa, Knight-Swift, NiSource April 16, 2026 4:37 PM - StreetInsider Form 424B5 Trevi Therapeutics, Inc. April 16, 2026 4:16 PM - SEC Filing Trevi Therapeutics announces $150 million public stock offering April 16, 2026 4:08 PM - StreetInsider Trevi Therapeutics Announces Proposed Public Offering of Common Stock April 16, 2026 4:08 PM - Globe NewsWire Form PRE 14A Trevi Therapeutics, Inc. For: Apr 10 April 10, 2026 4:33 PM - SEC Filing Trevi Therapeutics to Participate in Upcoming Events April 1, 2026 7:30 AM - Globe NewsWire Form SCHEDULE 13G/A Trevi Therapeutics, Inc. Filed by: VANGUARD GROUP INC March 27, 2026 1:32 PM - SEC Filing Trevi Therapeutics (TRVI) PT Lowered to $24 at Jones Trading March 19, 2026 7:01 AM - StreetInsider Trevi Therapeutics (TRVI) PT Lowered to $18 at Morgan Stanley March 18, 2026 7:51 AM - StreetInsider Trevi Therapeutics (TRVI) PT Raised to $24 at Needham March 18, 2026 7:19 AM - StreetInsider Cantor Fitzgerald Reiterates Overweight Rating on Trevi Therapeutics (TRVI) March 18, 2026 6:59 AM - StreetInsider Trevi Therapeutics (TRVI) Tops Q4 EPS by 4c March 17, 2026 4:15 PM - StreetInsider Form 10-K Trevi Therapeutics, Inc. For: Dec 31 March 17, 2026 4:10 PM - SEC Filing Form 8-K Trevi Therapeutics, Inc. For: Mar 17 March 17, 2026 4:08 PM - SEC Filing Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates  March 17, 2026 4:06 PM - Globe NewsWire Full Article List